Inactive
Total Small Business Set-Aside (FAR 19.5)
Notice ID:75N98023R00012
The purpose of the acquisition is to provide a variety of critical cancer prevention information management functions necessary to support the identification, development, and qualification of potenti...
The purpose of the acquisition is to provide a variety of critical cancer prevention information management functions necessary to support the identification, development, and qualification of potential cancer preventive agents for Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for clinical trials. Support for cancer preventive agent development includes the gathering and organizing of information from the research, pharmaceutical, and medical literature; preclinical and clinical technical project reports; scientific meetings; and private industry documents provided to the NCI under confidentiality agreements. Support also includes abstracting and maintaining databases of technical reports; abstracting application materials for the PREVENT Cancer Preclinical Drug Development Program (PREVENT); preparing specific chemical and biological agents and general class documents and structure/function and genomic/proteomic informational and statistical analyses for DCP programs; drafting and finalizing minutes of the PREVENT meetings; and identifying and reporting potential opportunities in cancer preventive agent development research.
